Call For Abstracts
The 25th Annual Napa Pain Conference
The Napa Pain Conference welcomes physicians, nurses, pharmacists, psychologists and other health care professionals to learn the latest information necessary to diagnose, treat, and manage acute and chronic pain, and associated comorbidities.
Generalists and specialists will benefit from a wide range of topics and faculty presenting basic, translational and the latest treatment advancements.
2018 AGENDA TO BE ANNOUNCED
The Napa Pain Conference is a forum where attendees discuss and learn the latest evidence for the treatment of pain. Participants receive new information and strategies to integrate advancements into their clinical practice.
Physicians, generalist and specialists, including but not limited to: internal medicine, primary care physicians, anesthesiologists, pain management and interventional pain management, emergency medicine, and any physician seeking to better address chronic or acute pain within their patients.
Provided education will also be of benefit to researchers, physician assistants, nurses, allied health professionals, and other health professions.
It has become important for healthcare providers to implement multifaceted interventions to treat chronic pain, reducing the risks for opioid over-prescribing, misuse, and diversion, without limiting appropriate access to treatment. As with every rapidly evolving specialty, existing practitioners must learn how to implement best practices related to advancements in patient care, patient adherence, assessment, and evaluation, and prescriber and patient communication.
Chronic pain alone affects at least 116 million US adults, yet health care professionals are not well educated in emerging clinical understanding and best practices in pain prevention and treatment.
In the United States, opiate use, misuse and diversion has reached epidemic proportions. In 2012, over 5% of the U.S. population, aged 12 and over, used opioid pain relievers non-medically. 40,393 drug overdose deaths occurred in the United States in 2010 – the equivalent of 46 deaths EVERY Day.
29% of PCPs prescribe opioids less often than they deem appropriate because of regulatory oversight concerns. The field of pain management is subject to high levels of regulatory, media, and government scrutiny, increasing liability and litigiousness stemming from alleged over treatment and under treatment.
Younger providers are more reluctant to prescribe opioids and experience more stress in managing patients with pain, have less overall confidence in managing patients with pain, and are more worried about opioid dependence than older providers (p <0.05). Younger patients are also less knowledgeable about opioids. New Guidelines issued by the CDC in March of 2016 are useful in directing physicians in how and when to use opiate prescription medications appropriately as well as when to refer for interventional treatment options. Clinicians are only vaguely aware of the new CDC guidelines and interventional options. In 2016 the Centers for Medicare and Medicaid instituted new payment under MIPs and MACRA to focus on value based or outcomes based care instead of fee for service. 89% of PCP studied express concern about medication misuse. 82% of PCPs are worried about opioid addiction among patients. 84% of PCP feel that managing patients with chronic pain is stressful. Half of IDDS maintenance claims were associated with death or permanent severe injury, most commonly from medication errors or failure to recognize progressive neurologic deterioration. LEARNING OBJECTIVES • Diagnose, treat and manage patients with pain; • Communicate with, and implement treatment plans for patients with chronic pain; • Differentiate treatment approaches medical vs. interventional for neuropathic pain; • Apply expanded understandings of the neurology and/or physiology of pain patients to improve patient interactions; • Identify patients who will benefit from neurostimulation; • Differentiate current and emerging neurostimulation devices for use in the treatment of chronic pain; • Utilize or make referrals to assess the viability of intrathecal drug delivery for the treatment of chronic pain; • Modify prescribing behaviors to align with best practices for limiting misuse or diversion of prescription medication; • Evaluate patients who will benefit from regenerative medicine, and be able to refer such patients or prepare to include regenerative medicine within their practice, • Recommend alternative/adjunctive treatments for pain patients, including counseling, and cognitive behavioral therapy; • Modify their practice to align with the March 2016 CDC Guidelines for Prescribing Opiate Medication for Chronic Pain; • Make necessary changes in preparation for MIPS and MACRA as they relate to potential impacts for their practice and ability to effectively treat chronic pain patients; and • Integrate multidisciplinary and/or multimodal pain treatments for patients with chronic pain.